Patents by Inventor Daniel Christopher Kirouac

Daniel Christopher Kirouac has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DIAGNOSTIC AND THERAPEUTIC METHODS FOR CANCER
    Publication number: 20190032150
    Abstract: The present invention provides diagnostic and therapeutic methods and compositions for cancer. The invention provides methods of determining whether a patient having a cancer is likely to respond to treatment comprising a MAPK signaling inhibitor, methods of predicting responsiveness of a patient having a cancer to treatment comprising one or more MAPK signaling inhibitors, methods of selecting a therapy for a patient having a cancer, and methods of treating cancer based on expression levels of biomarkers of the invention (e.g., the expression levels of DUSP6, ETV4, SPRY2, SPRY4, PHLDA1, ETV5, DUSP4, CCND1, EPHA2, and EPHA4).
    Type: Application
    Filed: October 11, 2018
    Publication date: January 31, 2019
    Inventors: Daniel Christopher Kirouac, Marie-Claire Wagle, Shih-Min Huang
  • DEVICE AND METHOD FOR CULTURING CELLS
    Publication number: 20160274111
    Abstract: A device and method for culturing cells is described. Culture media is continuously or intermittently delivered to the cell culture for diluting concentration of at least one marker component in the cell culture. The concentration of the marker component may be measured continuously or intermittently to determined the culture media delivery rate.
    Type: Application
    Filed: May 27, 2016
    Publication date: September 22, 2016
    Inventors: Peter Zandstra, Elizabeth Csaszar, Daniel Christopher Kirouac, Caryn Ito
  • DEVICE AND METHOD FOR CULTURING CELLS
    Publication number: 20120295289
    Abstract: A device and method for culturing cells is described. Culture media is continuously or intermittently delivered to the cell culture for diluting concentration of at least one marker component in the cell culture. The concentration of the marker component may be measured continuously or intermittently to determined the culture media delivery rate.
    Type: Application
    Filed: July 27, 2010
    Publication date: November 22, 2012
    Applicant: THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO
    Inventors: Peter Zandstra, Elizabeth Csaszar, Daniel Christopher Kirouac, Caryn Ito